Detalhe da pesquisa
1.
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
N Engl J Med
; 385(7): 595-608, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34379922
2.
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
Antimicrob Agents Chemother
; 67(4): e0005323, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36995219
3.
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Lancet
; 399(10337): 1779-1789, 2022 05 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35378077
4.
Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial.
BMC Infect Dis
; 23(1): 319, 2023 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37170118
5.
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
J Infect Dis
; 226(12): 2170-2180, 2022 12 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36240386
6.
Multiple Infection and Human Immunodeficiency Virus Superinfection Among Persons who Inject Drugs in Indonesia and Ukraine.
J Infect Dis
; 226(12): 2181-2191, 2022 12 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36346452
7.
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
J Infect Dis
; 225(10): 1741-1749, 2022 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35301540
8.
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial.
Clin Trials
; 19(6): 605-612, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36053045
9.
Association between drug use and ART use among people living with HIV who inject drugs in Vietnam, Ukraine and Indonesia: results from HPTN 074.
J Subst Use
; 27(6): 648-657, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36742268
10.
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
J Infect Dis
; 224(9): 1581-1592, 2021 11 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33740057
11.
Exploring individual-level barriers to HIV medication adherence among men who have sex with men in the HIV Prevention Trials Network (HPTN 065) study.
AIDS Care
; 33(11): 1404-1413, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33025791
12.
Examining stigma, social support, and gender differences in unsuppressed HIV viral load among participants in HPTN 065.
J Behav Med
; 44(2): 159-171, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33161564
13.
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Lancet
; 392(10149): 747-759, 2018 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30191830
14.
Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs.
AIDS Behav
; 23(8): 2101-2108, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-30600453
15.
Expanding Hospital Human Immunodeficiency Virus Testing in the Bronx, New York and Washington, District of Columbia: Results From the HPTN 065 Study.
Clin Infect Dis
; 66(10): 1581-1587, 2018 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29186421
16.
Social Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061.
AIDS Behav
; 21(4): 1163-1170, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27480454
17.
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
Trials
; 25(1): 124, 2024 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38360750
18.
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083.
Lancet Reg Health Am
; 18: 100416, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36844011
19.
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women.
J Int AIDS Soc
; 26(6): e26118, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37363917
20.
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysis.
J Int AIDS Soc
; 26 Suppl 2: e26109, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37439080